Alnylam Pharmaceuticals, Inc.
United States of America
Discovers, develops, and commercializes RNA interference (RNAi) therapeutics
Markets ONPATTRO, AMVUTTRA, GIVLAARI, and OXLUMO for rare diseases
Cambridge, Massachusetts, United States
会社名
Group
親会社
子会社
得意先
仕入先
業務提携
銀行等
株主等
2026-07-11 17:32 (Model: )
